Feb. 18 (UPI) -- Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company announced Wednesday.
Officials at the Food and Drug Administration have agreed to undertake a review of Moderna's seasonal influenza vaccine.
Moderna and FDA officials recently met to discuss the vaccine's review with the goal date of Aug. 5.
"Pending FDA approval, we look forward to making our flu vaccine available later this year so that America's seniors have access to a new option to protect themselves against flu," Moderna Chief Executive Officer Stephane Bancel said.
Related
